Health Care Industry
Industry: Email Alert RSS FeedGlaxo toll-free number in FDA trouble
Medical Marketing and Media, Aug 1999 by Dickinson, James G
>The Food and Drug Administration's Division of Drug Marketing, Advertising, and Communications says it is concerned about a call center response physicians could receive on Glaxo Wellcome's Agenerase (amprenavir). In a letter to the company, the DDMAC said a representative staffing a toll-free telephone number given to physicians "provided a promotional message that included several false or misleading statements about the resistance profile of Agenerase." Most RecentHealth Care Articles
- How to choose the right insurance carrier for your business
- Real Estate: Prepare your properties to weather what lies ahead
- Technology: Be prepared if part of your global supply chain goes missing
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- Design a commission plan that drives sales - Sales Commissions
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
- LIFO vs. FIFO: a return to the basics
Most Popular Business Publications
Content provided in partnership with
